Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension

ConclusionDual therapy with LCZ 696 plus bosentan proved significantly superior beneficial effect to LCZ 696 or bosentan alone on vascular remodelling and severity of experimental PH.

https://academic.oup.com/cardiovascres/article/117/5/1391/5870372?rss=1

Source: Cardiovascular Research - July 11, 2020 Category: Cardiology Source Type: research